As of 2025-04-24, the Relative Valuation of Homology Medicines Inc (FIXX) is (1,187.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -4936.9%.
The range of the Relative Valuation is (860.06) - (1,725.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 23.3x | 14.5x |
| Forward P/E multiples | 10.1x - 20.3x | 13.5x |
| Fair Price | (860.06) - (1,725.20) | (1,187.45) |
| Upside | -3603.3% - -7127.3% | -4936.9% |
| Date | P/E |